Le Lézard
Classified in: Business
Subject: ECO. NEWS, TRENDS, ANALYSIS

Quebec Bourse supports a reduction of the regulatory burden for public companies


MONTRÉAL, QUÉBEC--(Marketwired - July 27, 2017) - Québec Bourse Inc. has submitted today its comments to the Canadian Securities Administrators (CSA) public consultation aiming at reducing the regulatory burden for public companies.

Stock exchange listed companies are key to our economy. They are subject to a complex regulatory framework which entails significant compliance costs. This is often raised as a major obstacle by companies contemplating an IPO.

We must take a close look at the current regulatory framework and the relevance and appropriateness of all the requirements. There is an urgent need to act if we want a dynamic, efficient stock market that can compete with the other available sources of capital and the early divestiture of companies.

There is a significant imbalance between the regulatory burden, compliance costs and investor protection. Obviously, investor protection must remain a priority. However, today's regulatory environment has resulted in an overload of information and documentation which does not necessarily serve investors well.

Our main recommendations include:

About Québec Bourse:

Québec Bourse Inc. is an association regrouping Québec public companies and other stakeholders forming the public market ecosystem. Founded officially in 2016, Québec Bourse counts more than 90 members. Established as the voice of Québec's public companies and their key representative in dealing with regulatory and government authorities, Québec Bourse also aims among other things, to increase members' visibility, to foster collaboration, networking and exchange of best practices among members.


These press releases may also interest you

at 07:15
Flow Capital Corp. ("Flow Capital"), a leading provider of flexible growth capital solutions, is pleased to announce the full repayment of a USD 4.5 million investment in an environmental solutions provider. Flow Capital continues to focus on...

at 07:10
bluebird bio, Inc. announced today that it will host a conference call to discuss first quarter 2024 results and business updates on May 9, at 8:00 a.m. ET. To participate in the conference call, please dial +1 (800) 715-9871 (U.S. and Canada) and...

at 07:05
Stoke Therapeutics, Inc. , a biotechnology company dedicated to addressing the underlying cause of severe diseases by upregulating protein expression with RNA-based medicines, today reported financial results for the first quarter of 2024 and...

at 07:00
Total 1Q 2024 net product revenue of $75.0 million, representing 160% year-over-year growth Auvelity® 1Q 2024 net product sales of $53.4 million, representing 240% year-over-year growth Sunosi® 1Q 2024 net product revenue of $21.6 million...

at 07:00
Brookfield Asset Management ("Brookfield") and Castlelake L.P. ("Castlelake"), an alternatives asset manager specializing in asset-based private credit including aviation and specialty finance, today announced that they have entered into an...

at 07:00
LSL PHARMA GROUP INC. ("the Company" or "LSL Pharma"), a Canadian integrated pharmaceutical company, is pleased to announce that it has entered into a binding Letter of Intent ("LOI") to acquire profitable privately held, Quebec-based competing...



News published on and distributed by: